Kaku K, Wanner C, Anker SD, Pocock S, et al. The effect of empagliflozin on the total burden of cardiovascular and hospitalization events in the Asian and non-Asian populations of the EMPA-REG OUTCOME trial of patients with type 2 diabetes and cardiovascular disease. Diabetes Obes Metab 2021 Dec 14. doi: 10.1111/dom.14626.
PMID: 34908223